mechanism 3,033 words KG: NAD+
Contents

NAD+ Metabolism in Neurodegeneration

Mechanism Info
NameNAD+
Key Genes/ProteinsAMPK, CD38, CX43, PARP1, SIRT1, SIRT6
Linked Hypotheses21 hypotheses

No AI portrait yet

Knowledge Graph

Agent Input

Related Hypotheses (20)

NAD+-Dependent Transcriptional Upregulation of MCT1 to Resto
Score: 0.00
CD38 Inhibition to Preserve NAD+ Pools and Prevent PARP1-Med
Score: 0.00
NAD+-Dependent Upregulation of MCT1 Expression to Restore Ne
Score: 0.00
NAD+-SIRT1-H3K9me3 restoration enables true senescence rever
Score: 0.00
CD38 Inhibition to Prevent NAD+ Depletion and Restore Cellul
Score: 0.00
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A
Score: 0.79
H3: SIRT1 Insufficiency Disconnects Metabolic Sensing from E
Score: 0.77
PARP1-NAD+-AIF bioenergetic collapse drives a self-amplifyin
Score: 0.76
Senescence-Activated NAD+ Depletion Rescue
Score: 0.76
Metabolic NAD+ Salvage Pathway Enhancement Through NAMPT Ove
Score: 0.75
Metabolic Inflexibility Precedes Transcriptional Reprogrammi
Score: 0.73
NAD+ Decline and SIRT1 Deficiency Drive Epigenetic Reprogram
Score: 0.70
SARM1-Mediated NAD+ Depletion as Terminal Executor of MCT1-D
Score: 0.70
Mitochondrial NAD+ Salvage Enhancement
Score: 0.64
NAMPT-Centered NAD+ Restoration to Reverse Basal Forebrain C
Score: 0.62
SIRT6-NAD+ Axis Enhancement Therapy
Score: 0.61
NAD+/SARM1 Axis Provides Metabolic Feedback Coupling Mitopha
Score: 0.58
CD38 Inhibition for NAD+ Restoration and Microglial Senescen
Score: 0.57
NAD+ Precursor Supplementation to Reverse Poly(ADP-ribose) P
Score: 0.55
SIRT1 Activator Therapy for Mitochondrial Epigenetic Dysregu
Score: 0.48

Knowledge Graph (12 edges)

NAD+ activates SIRT1
AMPK contributes_to NAD+
NAD+ regulates SIRT1
NAD+ modulates SIRT1
CD38 depletes NAD+
PARP degrades NAD+
SIRT degrades NAD+
NAD+ protects_against BLOOD-BRAIN BARRIER DAMAGE
NAD+ associated_with Cellular Processes
NAD+ modulates inflammation

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...